Wheatley MedTech Partners

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$7M
Portfolio companies 2
Lead investments 0
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical
  • Ediscovery
Summary

The top amount of exits for fund were in 2013. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2012. Deals in the range of 5 - 10 millions dollars are the general things for fund.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care. Among the most popular portfolio startups of the fund, we may highlight Oligomerix, Enanta Pharmaceuticals.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Wheatley MedTech Partners, startups are often financed by Techno Venture Management, Oxford Bioscience Partners, Advent International. The meaningful sponsors for the fund in investment in the same round are Yasuda Enterprise Development, Wheatley Partners, Techno Venture Management. In the next rounds fund is usually obtained by Thuja Capital, Techno Venture Management, Oxford Bioscience Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Wheatley MedTech Partners:
Typical Co-investors
Wheatley MedTech Partners is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Wheatley MedTech Partners:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aleph Capital Partners England, London, United Kingdom
Bharti Enterprises Delhi, India, New Delhi
GMO Boston, Massachusetts, United States
Haflo Stockholm, Stockholm County, Sweden
iHealthtech ,NUS -
Medwell Capital Alberta, Canada, Edmonton
Perivoli Innovations -
Qicheng Information Technology -
Rona Syndicates California, San Mateo, United States
Zhe Xin Ziben China, Guangdong, Shenzhen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Oligomerix

Biotechnology
Ediscovery
Medical
$2M23 Apr 2012 New York, United States

Enanta Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$12M14 Jan 2004 Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Wheatley MedTech Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: